ACE-Neuro: A tailored exercise oncology program for neuro-oncology patients - Study protocol

Area of Science:

• Neuro-oncology
• Exercise Oncology
• Cancer Rehabilitation

Background:

• Primary brain tumor patients, or neuro-oncology patients, have limited access to exercise oncology and wellness resources.
• The Alberta Cancer Exercise - Neuro-Oncology (ACE-Neuro) study addresses this gap by assessing a tailored exercise program for these patients in Alberta, Canada.

Purpose of the Study:

• To determine the feasibility of the ACE-Neuro program.
• To examine the preliminary effectiveness of ACE-Neuro on patient-reported outcomes and functional fitness.

Main Methods:

• Eligible participants include neuro-oncology patients over 18, pre, on, or post-treatment for primary brain tumors.
• Participants undergo a 12-week tailored exercise program (individual/group sessions, health coaching) with pre-post assessments.
• Objective physical activity is tracked throughout the 12-week program.

Main Results:

• The study focuses on assessing the feasibility of the ACE-Neuro program.
• Preliminary effectiveness on patient-reported outcomes and functional fitness is a secondary outcome.

Conclusions:

• The ACE-Neuro study supports the implementation of tailored exercise interventions into clinical cancer care.
• Needs assessment is crucial for developing effective, individualized exercise prescriptions for neuro-oncology patients.